This study seeks to determine how COVID-19 affects the clinical outcome of patients with chronic liver disease, and whether the clinical course of COVID-19 is influenced by underlying chronic liver disease.
Other: Prospective Chart Review
Collected data will include demographic features, clinical characteristics, clinical outcome, medication use, COVID-19-related complications in patients with chronic liver disease.
Inclusion Criteria:
- Confirmed diagnosis of COVID-19
- Personal history of either
- Chronic hepatitis C
- Chronic hepatitis B
- Alcoholic liver disease
- Non alcoholic liver disease
- Autoimmune hepatitis, Primary biliary cholangitis, Primary sclerosing cholangitis
- Cryptogenic cirrhosis
- Hepatocellular carcinoma
Exclusion Criteria:
- Non-COVID-19 patient
University of Arizona,
Phoenix, Arizona, United States
Mayo Clinic
Scottsdale, Arizona, United States
UCSF Fresno
Fresno, California, United States
University of Southern California
Los Angeles, California, United States
Stanford University
Stanford, California, United States
Georgetown University
Washington, District of Columbia, United States
VA Medical Center
Washington, District of Columbia, United States
University of Miami
Miami, Florida, United States
Rush University Medical Center
Chicago, Illinois, United States
The University of Kansas Medical Center
Kansas City, Kansas, United States
Oschner Medical Center
Baton Rouge, Louisiana, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Brigham and Women's Hospital
Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
University of Michigan
Ann Arbor, Michigan, United States
Hennepin County Medical Center (HCMC)
Minneapolis, Minnesota, United States
University of Minnesota
Minneapolis, Minnesota, United States
Mount Sinai School of Medicine
New York, New York, United States
Weill Cornell Medicine
New York, New York, United States
Duke University
Durham, North Carolina, United States
University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
Renumathy Dhanasekaran, MD, Principal Investigator
Stanford University